These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11431204)
21. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Corrigan G; Stevens PE Aliment Pharmacol Ther; 2000 Jan; 14(1):1-6. PubMed ID: 10632639 [TBL] [Abstract][Full Text] [Related]
22. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Prantera C; Cottone M; Pallone F; Annese V; Franzè A; Cerutti R; Bianchi Porro G Gastroenterology; 1999 Mar; 116(3):521-6. PubMed ID: 10029609 [TBL] [Abstract][Full Text] [Related]
24. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease]. Moum B Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043 [TBL] [Abstract][Full Text] [Related]
25. [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease]. Park JE; Hwangbo Y; Chang R; Chang YW; Jang JY; Kim BH; Dong SH; Kim HJ Korean J Gastroenterol; 2009 Feb; 53(2):116-20. PubMed ID: 19237838 [TBL] [Abstract][Full Text] [Related]
26. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103 [TBL] [Abstract][Full Text] [Related]